GeneIII Biotech’s "Global Evidence-Based Journey" in Singapore highlights its leadership in the Ergothioneine (EGT) industry. By partnering with Professor Barry Halliwell at the National University of Singapore and the Temasek Life Sciences Laboratory, GeneIII bridges the gap between synthetic biology and clinical applications, particularly in neuroprotection and ovarian health.